» Articles » PMID: 24072989

Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications

Overview
Journal Sleep Med Clin
Publisher Elsevier
Specialty Psychiatry
Date 2013 Sep 28
PMID 24072989
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis of insomnia is based solely on subjective complaints. This has contributed to the low reliability and validity of the current nosology of insomnia as well as to its lack of firm association with clinically relevant outcomes such as cardiometabolic and neurocognitive morbidity. We review evidence that insomnia with objective short sleep duration is associated with physiological hyperarousal, higher risk for hypertension, diabetes, neurocognitive impairment, and mortality as well as with a persistent course. It also appears that objective short sleep duration in poor sleepers is a biological marker of genetic predisposition to chronic insomnia. In contrast, insomnia with objective normal sleep duration is associated with cognitive-emotional and cortical arousal and sleep misperception but not with signs of physiological hyperarousal or medical complications. Thus, short sleep duration in insomnia may be a reliable marker of the biological severity and medical impact of the disorder. We propose that (a) objective measures of sleep be included in the diagnosis of insomnia and its subtypes, (b) objective measures of sleep obtained in the home environment of the patient would become part of the routine assessment and diagnosis of insomnia in a clinician's office setting, and (c) insomnia with short sleep duration may respond better to biological treatments, whereas insomnia with normal sleep duration may respond primarily to psychological therapies.

Citing Articles

2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults - Brazilian Sleep Association.

Drager L, Assis M, Bacelar A, Poyares D, Conway S, Pires G Sleep Sci. 2024; 16(Suppl 2):507-549.

PMID: 38370879 PMC: 10869237. DOI: 10.1055/s-0043-1776281.


Daytime autonomic nervous system functions differ among adults with and without insomnia symptoms.

McCall W, Looney S, Zulfiqar M, Ketcham E, Jones M, Mixson C J Clin Sleep Med. 2023; 19(11):1885-1893.

PMID: 37421322 PMC: 10620659. DOI: 10.5664/jcsm.10704.


Animal models of human insomnia.

Fernandez F, Perlis M J Sleep Res. 2023; 32(6):e13845.

PMID: 36748845 PMC: 10404637. DOI: 10.1111/jsr.13845.


Association of insomnia and short sleep duration, alone or with comorbid obstructive sleep apnea, and the risk of chronic kidney disease.

Beaudin A, Raneri J, Ahmed S, Hirsch Allen A, Nocon A, Gomes T Sleep. 2022; 45(7).

PMID: 35445715 PMC: 9272259. DOI: 10.1093/sleep/zsac088.


The relationship between the HDRS insomnia items and polysomnographic (PSG) measures in individuals with treatment-resistant depression.

Hejazi N, Farmer C, Oppenheimer M, Falodun T, Park L, Duncan Jr W J Psychiatr Res. 2022; 148:27-33.

PMID: 35092868 PMC: 8957609. DOI: 10.1016/j.jpsychires.2022.01.022.


References
1.
Buysse D, Ancoli-Israel S, Edinger J, Lichstein K, Morin C . Recommendations for a standard research assessment of insomnia. Sleep. 2006; 29(9):1155-73. DOI: 10.1093/sleep/29.9.1155. View

2.
Varkevisser M, Van Dongen H, van Amsterdam J, Kerkhof G . Chronic insomnia and daytime functioning: an ambulatory assessment. Behav Sleep Med. 2007; 5(4):279-96. DOI: 10.1080/15402000701557425. View

3.
Lanfranchi P, Pennestri M, Fradette L, Dumont M, Morin C, Montplaisir J . Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009; 32(6):760-6. PMC: 2690563. DOI: 10.1093/sleep/32.6.760. View

4.
Vgontzas A, Kales A . Sleep and its disorders. Annu Rev Med. 1999; 50:387-400. DOI: 10.1146/annurev.med.50.1.387. View

5.
Varkevisser M, Van Dongen H, Kerkhof G . Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal?. Sleep. 2006; 28(12):1588-96. View